Shawn M Aarde1, Pai-Kai Huang1, Michael A Taffe2. 1. Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA. 2. Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA. Electronic address: mtaffe@scripps.edu.
Abstract
RATIONALE: MDMA alters body temperature in rats with a direction that depends on the ambient temperature (TA). The thermoregulatory effects of MDMA and TA may affect intravenous self-administration (IVSA) of MDMA but limited prior reports conflict. OBJECTIVE: To determine how body temperature responses under high and low TA influence MDMA IVSA. METHODS: Male Sprague-Dawley rats were trained to IVSA MDMA (1.0mg/kg/infusion; 2-h sessions; FR5 schedule of reinforcement) under TA 20°C or 30°C. Radiotelemetry transmitters recorded body temperature and activity during IVSA. RESULTS: MDMA intake increased under both TA during acquisition, but to a greater extent in the 30°C group. The magnitude of hypothermia was initially equivalent between groups but diminished over training in the 30°C group. Within-session activity was initially lower in the 30°C group, but by the end of acquisition and maintenance, activity was similar for both groups. When TA conditions were swapped, the hot-trained group increased MDMA IVSA under 20°C TA and a modest decrease in drug intake was observed in the cold-trained group under 30°C TA. Subsequent non-contingent MDMA (1.0-5.0mg/kg, i.v.) found that rats with higher MDMA IVSA rates showed blunted hypothermia compared with rats with lower IVSA levels; however, within-session activity did not differ by group. High TA increased intracranial self-stimulation thresholds in a different group of rats and MDMA reduced thresholds below baseline at low, but not high, TA. CONCLUSIONS: High TA appears to enhance acquisition of MDMA IVSA through an aversive effect and not via thermoregulatory motivation.
RATIONALE: MDMA alters body temperature in rats with a direction that depends on the ambient temperature (TA). The thermoregulatory effects of MDMA and TA may affect intravenous self-administration (IVSA) of MDMA but limited prior reports conflict. OBJECTIVE: To determine how body temperature responses under high and low TA influence MDMA IVSA. METHODS: Male Sprague-Dawley rats were trained to IVSA MDMA (1.0mg/kg/infusion; 2-h sessions; FR5 schedule of reinforcement) under TA 20°C or 30°C. Radiotelemetry transmitters recorded body temperature and activity during IVSA. RESULTS:MDMA intake increased under both TA during acquisition, but to a greater extent in the 30°C group. The magnitude of hypothermia was initially equivalent between groups but diminished over training in the 30°C group. Within-session activity was initially lower in the 30°C group, but by the end of acquisition and maintenance, activity was similar for both groups. When TA conditions were swapped, the hot-trained group increased MDMA IVSA under 20°C TA and a modest decrease in drug intake was observed in the cold-trained group under 30°C TA. Subsequent non-contingent MDMA (1.0-5.0mg/kg, i.v.) found that rats with higher MDMA IVSA rates showed blunted hypothermia compared with rats with lower IVSA levels; however, within-session activity did not differ by group. High TA increased intracranial self-stimulation thresholds in a different group of rats and MDMA reduced thresholds below baseline at low, but not high, TA. CONCLUSIONS: High TA appears to enhance acquisition of MDMA IVSA through an aversive effect and not via thermoregulatory motivation.
Authors: Bruno Hurault de Ligny; Wael El Haggan; François Comoz; Thierry Lobbedez; Myriam Pujo; Anne Marie Griveau; Philippe Bottet; Henri Bensadoun; Jean Philippe Ryckelynck Journal: Transplantation Date: 2005-07-15 Impact factor: 4.939
Authors: Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe Journal: Psychopharmacology (Berl) Date: 2015-05-01 Impact factor: 4.530
Authors: Susan Schenk; Lincoln Hely; Barbara Lake; Evangelene Daniela; David Gittings; Deborah C Mash Journal: Eur J Neurosci Date: 2007-11-14 Impact factor: 3.386
Authors: Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Rick Doblin Journal: J Psychopharmacol Date: 2010-07-19 Impact factor: 4.153
Authors: Mark A Smith; Karl T Schmidt; Jessica L Sharp; Tallia Pearson; Anna L Davis; Abigail N Gibson; Kenzie M Potter Journal: Eur J Pharmacol Date: 2021-11-17 Impact factor: 4.432
Authors: Gia Valles; Jessica L Huebschman; Elsbeth Chow; Corinne Kelly; Yuhong Guo; Laura N Smith Journal: Front Behav Neurosci Date: 2022-06-15 Impact factor: 3.617
Authors: Mehrak Javadi-Paydar; Jacques D Nguyen; Tony M Kerr; Yanabel Grant; Sophia A Vandewater; Maury Cole; Michael A Taffe Journal: Psychopharmacology (Berl) Date: 2018-06-16 Impact factor: 4.530
Authors: Sophia Khom; Jacques D Nguyen; Sophia A Vandewater; Yanabel Grant; Marisa Roberto; Michael A Taffe Journal: Front Behav Neurosci Date: 2021-12-16 Impact factor: 3.617